Skip to main content
. 2020 Mar 23;12(3):290. doi: 10.3390/pharmaceutics12030290

Figure 5.

Figure 5

Schematic illustration of biological ligands used for active targeting in nanoparticles. Adapted from (Cancers. 2019, 11, E640. Multidisciplinary Digital Publishing Institute).